HUMAN PAPILLOMA VIRUS (HPV)
Clinical trials for HUMAN PAPILLOMA VIRUS (HPV) explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMA VIRUS (HPV) trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMA VIRUS (HPV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New gel could zap away common warts in just weeks
Disease control Recruiting nowThis study tests a medicated gel called YCANTH on common warts caused by HPV. About 300 people aged 2 and older with at least one wart will apply the gel or a fake version. The goal is to see if the gel safely clears all warts by day 84.
Matched conditions: HUMAN PAPILLOMA VIRUS (HPV)
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated May 26, 2026 05:54 UTC
-
Blood test may let HPV throat cancer patients avoid radiation
Disease control Recruiting nowThis study is for people with HPV-related throat cancer who have surgery to remove the tumor. Usually, patients with certain risk factors get radiation after surgery, but this can cause long-term side effects. The trial uses a blood test two weeks after surgery to check for lefto…
Matched conditions: HUMAN PAPILLOMA VIRUS (HPV)
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated May 26, 2026 05:54 UTC
-
New gel shows promise for stubborn warts in extended trial
Disease control Recruiting nowThis study follows people who previously took part in a wart treatment study (COVE-2 or COVE-3) to see if YCANTH gel is safe and works over a longer period. Participants with remaining warts can get up to 4 more treatments, applied every 21 days. The goal is to clear all warts, a…
Matched conditions: HUMAN PAPILLOMA VIRUS (HPV)
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
Massive health survey aims to uncover hidden disease threats in cambodia
Knowledge-focused Recruiting nowThis study will test 10,000 people in Cambodia for antibodies against 57 different infectious diseases, including dengue, flu, and malaria. The goal is to learn how these diseases spread in communities and which ones are most common. This information will help health officials de…
Matched conditions: HUMAN PAPILLOMA VIRUS (HPV)
Sponsor: Institut Pasteur du Cambodge • Aim: Knowledge-focused
Last updated May 26, 2026 05:57 UTC
-
Blood test may predict cervical cancer treatment success
Knowledge-focused Recruiting nowThis study is testing two blood tests that look for HPV DNA and RNA to see if they can track how well cervical cancer responds to surgery, radiation, and chemotherapy. About 55 adults with HPV-related cervical cancer will give blood samples before and after treatment. The goal is…
Matched conditions: HUMAN PAPILLOMA VIRUS (HPV)
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated May 26, 2026 05:54 UTC